Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ella Ariza‐Heredia"'
Autor:
Fareed Khawaja, Georgios Angelidakis, Adina Feldman, Vinod Ravi, Eric Woodman, Micah Bhatti, Ella Ariza‐Heredia, Peter Elhajj, Amy Spallone, Ying Jiang, Roy F. Chemaly
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22006-22022 (2023)
Abstract Background With the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic, the development of effective and safe vaccines was of utmost importance to protect vulnerable individuals, including cancer
Externí odkaz:
https://doaj.org/article/6fa7b6d43d4542b58eab3e455971b4cd
Publikováno v:
Open Forum Infectious Diseases. 10
Respiratory viral infections (RVIs) are of major clinical importance in immunocompromised patients and represent a substantial cause of morbidity and mortality in patients with hematologic malignancies and those who have undergone hematopoietic cell
Autor:
Krithia Srinivasan, Amy Spallone, Fareed Khawaja, Joseph Sassine, Oscar Morado Aramburo, Anthony J Febres-Aldana, Gabriella Rondon, Jeremy Ramdial, Elizabeth Shpall, Ella Ariza-Heredia, Roy F Chemaly
Publikováno v:
Open Forum Infectious Diseases. 9
Background Letermovir (LTV) has reduced non-relapse mortality (NRM) in allogeneic hematopoietic cell transplant (allo-HCT) recipients by reducing the rate of clinically significant cytomegalovirus infections (CS-CMVi). The impact of LTV prophylaxis (
Autor:
Marilyne Daher, Fareed Khawaja, Georgios Angelidakis, Gabriella Rondon, Amy Spallone, Jeremy Ramdial, Ella Ariza-Heredia, Elizabeth Shpall, Roy F Chemaly
Publikováno v:
Open Forum Infectious Diseases. 9
Background The Coronavirus Disease 2019 (COVID-19) has significantly impacted cancer patients with some reported mortality as high as 25%. The Immunodeficiency Scoring Index (ISI) was developed as a prognostic tool in allogeneic hematopoietic cell tr
Autor:
Paolo Strati, Sandra B. Horowitz, Luis Fayad, Hun J. Lee, Victor E. Mulanovich, Swapna Johncy, Sairah Ahmed, Sherry Adkins, Ankur Varma, Felipe Samaniego, Nathan Fowler, Sara Arafat, Jason R. Westin, Loretta J. Nastoupil, Ella Ariza Heredia, Fredrick B. Hagemeister, Yiming Chen, Sattva S. Neelapu, Partow Kebriaei
Publikováno v:
Haematologica
Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 may be associated with long-term adverse effects such as cytopenia and immune deficiency. In order to characterize these late events, we analyzed 31 patients with relapsed or refractory la
Autor:
Amy Spallone, Fareed Khawaja, Ella Ariza-Heredia, Genovefa A Papanicolaou, Michael J. Boeckh, Sanjeet S. Dadwal, Maheen Z. Abidi, Jose F. Camargo, Zeinab El Boghdadly, Zainab Shahid, Roy F. Chemaly
Publikováno v:
Transplantation and Cellular Therapy. 28:S375-S376
Autor:
Victor E. Mulanovich, Roy F. Chemaly, Natalie Dailey Garnes, Fareed Khawaja, Georgios Angelidakis, Ella Ariza Heredia
Publikováno v:
Microbes and infection. 24(3)
Baloxavir, a cap-dependent endonuclease inhibitor, was recently approved for treatment of severe influenza infections. Combining baloxavir with oseltamivir has been proposed to increase the response rate. We report 2 hematopoietic cell transplant rec
Autor:
Joseph Sassine, Fareed Khawaja, Brandon R Shank, Alexandra Lovell, Jenessa Lee, Adam DiPippo, Caitlin R Rausch, Amy Spallone, Ella Ariza Heredia, Roy F Chemaly
Publikováno v:
Open Forum Infectious Diseases. 8:S557-S558
Background Clinically significant CMV infections (CS-CMVi) among patients with lymphoma and multiple myeloma (MM) have not been clearly defined, especially considering the new cancer therapies that have revolutionized cancer outcomes of these patient
Autor:
Yuexin Tang, Roy F. Chemaly, Ella Ariza Heredia, Amit D. Raval, Fareed Khawaja, Joseph Sassine, Lynn El Haddad, Kathleen M. Mullane
Publikováno v:
Open Forum Infectious Diseases
Background CMV reactivation is associated with significant morbidity and mortality in allo-HCT recipients and could be a resource intensive condition to manage. Limited data are available on the economic ramification of CMV reactivation in allo-HCT.
Autor:
Joseph Sassine, Fareed Khawaja, Victoria Handy, Terri Lynn Shigle, Farnaz Foolad, Samuel L Aitken, Ella Ariza Heredia, Roy F Chemaly
Publikováno v:
Open Forum Infectious Diseases
Background CMV reactivation is one of the most common infections after allogeneic hematopoietic cell transplantation (allo-HCT) and carries considerable morbidity and mortality. Primary prophylaxis with letermovir demonstrated in clinical trials redu